Gossamer Bio (GOSS) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -4.35%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.19 per share when it actually produced a loss of $0.19, delivering no surprise. Over the last four quarters, the company ...